The pharmacokinetics and pharmacodynamics of bumetanide in normal subjects
Tóm tắt
The pharmacokinetics and pharmacodynamics of bumetanide (1 mg) administered either orally or intravenously were studied in a group of normal subjects using high-pressure liquid chromatography. A two-compartment model adequately fitted the intravenous data. Renal clearance (85 ml min−1 contributed 65% to the total elimination of bumetanide irrespective of whether a model-dependent or model-independent method was used. Oral administration of bumetanide elicited a greater and a more prolonged pharmacological response than did intravenous bumetanide. An attempt is made to relate the pharmacokinetics of the drug to its pharmacodynamics.
Tài liệu tham khảo
J. L. Ashbury, P. B. B. Gatenby, S. O'Sullivan, and E. Bourke. Bumetanide: potent new ‘loop’ diuretic.Br. Med. J. 1:211–213 (1972).
K. H. Olesen, B. Sigurd, E. Steiness, and A. Leith. Bumetanide, a new potent diuretic. A clinical evaluation of congestive heart failure.Acta Med. Scand. 193:119–131 (1973).
W. R. Murdoch and W. H. R. Auld. Bumetanide-acute and long-term studies of a new high potency diuretic.Postgrad. Med. J. 51(Suppl. 6):64–69 (1975).
D. L. Davies, A. F. Lant, N. R. Millard, A. J. Smith, and J. W. Ward. Renal action, therapeutic use, and pharmacokinetics of the diuretic bumetanide.Clin. Pharmacol. Ther. 15:141–153 (1974).
W. R. Dixon, R. L. Young, A. Holazo, M. L. Jack, R. E. Weinfeld, K. Alexander, A. Liebman, and S. A. Kaplan. Bumetanide: radioimmunoassay and pharmacokinetic profile in humans.J. Pharm. Sci. 65:701–704 (1976).
P. J. Pentikäinen, A. Penttilä, P. J. Neuvonen, and G. Gothoni. Fate of [14C] bumetanide in man.Br. J. Clin. Pharmacol. 4:39–44 (1977).
P. J. Pentikäinen, P. J. Neuvonen, M. Kekki, and A. Penttilä. Pharmacokinetics of intravenously administered bumetanide in man.J. Pharmacokin. Biopharm. 8:219–228 (1980).
L. A. Marcantonio, W. H. R. Auld, and G. G. Skellern. Determination of the diuretic bumetanide in biological fluids by high-performance liquid chromatography.J. Chromatogr. 183:118–123 (1980).
C. M. Metzler, G. L. Elfring, and A. J. McEwan. A package of computer programs for pharmacokinetic modeling.Biometrics 30:562–580 (1974).
M. Gibaldi and D. Perrier.Pharmacokinetics. Marcel Dekker, New York, 1975.
S. C. Halladay, I. G. Sipes, and D. E. Carter. Diuretic effect and metabolism of bumetanide in man.Clin. Pharmacol. Ther. 22:179–187 (1977).
L. Z. Benet. Pharmacokinetics/pharmacodynamics of furosemide in man: a review.J. Pharmacokin. Biopharm. 7:1–27 (1979).
B. Beerman and M. Groschinsky-Grind. Clinical pharmacokinetics of diuretics.Clin. Pharmacokin. 5:221–245 (1980).
B. Fox, C. Brater, J. Beck, and P. Chennavasin. Comparison of i.v. bumetanide to furosemide in normal volunteers.Pharmacologist 21:185 (1979).
P. N. Underwood and P. R. Hunter. Evaluation of once daily versus twice daily bumetanide in heart failure.Postgrad. Med. J. 51(Suppl. 6):91–95 (1975).